TMO financials
Thermo Fisher (TMO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TMO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $44.56B | $18.24B | $8.11B | $6.74B | 17.74 |
| 2024 | $42.88B | $17.73B | $7.66B | $6.33B | 16.53 |
| 2023 | $42.86B | $17.19B | $7.45B | $6.00B | 15.45 |
| 2022 | $44.91B | $19.01B | $8.53B | $6.95B | 17.64 |
| 2021 | $39.21B | $19.63B | $10.32B | $7.72B | 19.46 |
| 2020 | $32.22B | $16.03B | $7.90B | $6.38B | 15.98 |
- TMO revenue was $44.56B in fiscal 2025, net income $6.74B.
Updated 2026-11-02 19:56 UTC